Value co-creation in healthcare: evidence from innovative therapeutic alternatives for hereditary angioedema

Spanó, Rosanna; Paola, Nadia Di; Bova, María; Barbarino, Alessandro

doi:10.1186/s12913-018-3389-y

Cited by 16 publications

(22 citation statements)

References 83 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among the most widely accepted definitions of co-creation are as follows: (1) Value cocreation is the joint creation of value by the company and the customers, allowing the customers to co-construct the service experience to suit their context (Prahalad and Ramaswamy, 2004). Subsequently, given that the co-creation of value not only affects the bilateral relationship between the consumer and the company, the definition has been transformed to incorporate the multiple agents involved in the process: and (2) Value co-creation describes the way actors behave, interact, interpret, experience, use, and evaluate propositions based on the social construction of which they are a part (Ranjan and Read, 2016).…”

Section: Conceptual Background: Co-creation Valuementioning

confidence: 99%

“…According to Merz et al (2018), the first of the categories comes from the literature on engagement and refers to the resources that the participating agents voluntarily offer so that co-creation can take place, such as their knowledge, skills, creativity, and network. This group of dimensions is what Ranjan and Read (2016) understand as co-production, which incorporates variables such as knowledge, equity, and interaction. The second category of dimensions, the favorable disposition toward co-creation, is based on the relationship literature, referring to the motivation of the actors to participate in the co-creation process, and refers to variables such as passion, commitment, and trust.…”

Section: Conceptual Background: Co-creation Valuementioning

confidence: 99%

“…The second category of dimensions, the favorable disposition toward co-creation, is based on the relationship literature, referring to the motivation of the actors to participate in the co-creation process, and refers to variables such as passion, commitment, and trust. Ranjan and Read (2016) call this second category value-in-use with dimensions of experience, personalization, and relationship. According to Verleye (2015), the dimensions that define the co-creation experience are hedonic experience, cognitive experience, social/personal experience, and pragmatic/economic experience.…”

Section: Conceptual Background: Co-creation Valuementioning

confidence: 99%

“…Co-creation process describes the way actors behave, interact, interpret, experience, use, and evaluate propositions based on the social construction of which they are a part. Value can extend into future processes beyond the instant realm of exchange or without the "direct" intervention of another party (e.g., through use, social relation, and joint construction) (Ranjan and Read, 2016) (1) Co-production: knowledge, equity and interaction (2) Value in use: experience, personalization, and relationship Co-creation describes the customer as an active participant and collaborative partner in relational exchanges, through involvement in the entire service value chain (Yi and Gong, 2013) (1) Customer participation: information seeking, information sharing, responsible behavior, and personal interaction (2) Customer citizenship: feedback, advocacy, helping, and tolerance seeking, information sharing, responsible behavior, and personal interaction, and those that determine the latter are feedback, advocacy, helping, and tolerance. According to Rubio et al (2019), in subsequent studies, these behaviors have been modified depending on the application context (brand communities, digital platforms, and social networks) (Tonteri et al, 2011;Tsai and Pai, 2013;Vernette and Hamdi-Kidar, 2013;Chen et al, 2014;Xu and Li, 2015;Chou et al, 2016;Hu et al, 2016).…”

Section: Co-creation Definitionsmentioning

confidence: 99%

See 3 more Smart Citations

Value Co-creation in Third-Party Managed Virtual Communities and Brand Equity

Villaseñor

Yagüe²

2020

Front. Psychol.

View full text Add to dashboard Cite

Value co-creation continues to be a key issue in the era of marketing 4.0. Despite an increasing amount of research on value co-creation, there is still a lot of ambiguity in the use of certain terms. For example, different names are used to refer to the same concept. Even though the concept of co-innovation or co-production has nearly the same meaning as co-creation, there are certain differences between them that must be clarified. In addition, another difficulty found in the literature is that the co-creation concept is frequently applied to different objects of study, such that it might be dealing with brand value co-creation, co-creation of experience, co-creation attitude, etc. In order to clarify these issues, this paper presents a brief review of the relevant literature on value co-creation.

show abstract

Section: Conceptual Background: Co-creation Valuementioning

confidence: 99%

Section: Conceptual Background: Co-creation Valuementioning

confidence: 99%

Section: Conceptual Background: Co-creation Valuementioning

confidence: 99%

Section: Co-creation Definitionsmentioning

confidence: 99%

See 2 more Smart Citations

Value Co-creation in Third-Party Managed Virtual Communities and Brand Equity

Villaseñor

Yagüe²

2020

Front. Psychol.

View full text Add to dashboard Cite

show abstract

“…Another important topic to be addressed regarding the evaluation of costs is the impact of health-care networking and organization. Spanò et al [67] highlighted that an alternative and innovative treatment strategy, i.e. selfadministration, by focusing on treatment outcomes and costs, can create value for patients and health-care systems.…”

Section: Costsmentioning

confidence: 99%

Current and emerging biologics for the treatment of hereditary angioedema

Perego

Valerieva

et al. 2019

Expert Opinion on Biological Therapy

View full text Add to dashboard Cite

Introduction: Hereditary angioedema due to C1-INH deficiency (C1-INH-HAE) is a rare disease with unpredictable, self-limiting and localized swelling episodes involving the cutaneous and subcutaneous tissues. In the last decade, the spectrum of the possibilities to control the disease has considerably changed with the development of biologic therapies making necessary a careful evaluation of the differences among current and emerging treatments to properly optimize the management of patients. Areas covered: This review serves to summarize the literature regarding the use of biologics for the treatment of C1-INH-HAE. Medications already available on the market and new drugs in different phases of development are addressed. Expert opinion: the advent of biologic therapies dramatically improved the lives of patients with C1-INH-HAE although further improvement is still needed. Whether this is cost/effective will be answered in the next years when we will see if these major advances will benefit the majority of the patients.

show abstract

A scoping review of neurodegenerative manifestations in explainable digital phenotyping

Alfalahi

Dias

Khandoker

et al. 2023

npj Parkinsons Dis.

View full text Add to dashboard Cite

Neurologists nowadays no longer view neurodegenerative diseases, like Parkinson’s and Alzheimer’s disease, as single entities, but rather as a spectrum of multifaceted symptoms with heterogeneous progression courses and treatment responses. The definition of the naturalistic behavioral repertoire of early neurodegenerative manifestations is still elusive, impeding early diagnosis and intervention. Central to this view is the role of artificial intelligence (AI) in reinforcing the depth of phenotypic information, thereby supporting the paradigm shift to precision medicine and personalized healthcare. This suggestion advocates the definition of disease subtypes in a new biomarker-supported nosology framework, yet without empirical consensus on standardization, reliability and interpretability. Although the well-defined neurodegenerative processes, linked to a triad of motor and non-motor preclinical symptoms, are detected by clinical intuition, we undertake an unbiased data-driven approach to identify different patterns of neuropathology distribution based on the naturalistic behavior data inherent to populations in-the-wild. We appraise the role of remote technologies in the definition of digital phenotyping specific to brain-, body- and social-level neurodegenerative subtle symptoms, emphasizing inter- and intra-patient variability powered by deep learning. As such, the present review endeavors to exploit digital technologies and AI to create disease-specific phenotypic explanations, facilitating the understanding of neurodegenerative diseases as “bio-psycho-social” conditions. Not only does this translational effort within explainable digital phenotyping foster the understanding of disease-induced traits, but it also enhances diagnostic and, eventually, treatment personalization.

show abstract

Value co-creation in healthcare: evidence from innovative therapeutic alternatives for hereditary angioedema

Cited by 16 publications

References 83 publications

Value Co-creation in Third-Party Managed Virtual Communities and Brand Equity

Value Co-creation in Third-Party Managed Virtual Communities and Brand Equity

Current and emerging biologics for the treatment of hereditary angioedema

A scoping review of neurodegenerative manifestations in explainable digital phenotyping

Contact Info

Product

Resources

About